Home Cellular science New startups from UC Davis research and innovation emerge with solutions in health, energy and agriculture

New startups from UC Davis research and innovation emerge with solutions in health, energy and agriculture

0


[ad_1]

In fiscal year 2020-21, nine startups signed agreements to access fundamental intellectual property and commercialize new technologies developed at the University of California, Davis.

The emerging startups focus on technological solutions to meet health needs, energy and agricultural.

“It is always exciting to see UC Davis innovations translated into commercial applications that benefit our regional economy and society as a whole,” said Prasant Mohapatra, vice chancellor for research at UC Davis. “Innovations from UC Davis and other universities around the world are instrumental in the development of new technologies that power the products and services of tomorrow. ”

One of the startups, Innate biology, markets supplements this may allow a consumer to enjoy the same cellular benefits as fasting, without having to fast. Co-founded by Angela Zivkovic, associate professor in the Department of Nutrition, the company participated in the IndieBio accelerator to advance their patent pending fast mimetic formulation focused on healthy living and longevity.

Reuse Energy, a clean energy startup co-founded by Jae Wan Park, associate professor in the Department of Mechanical and Aerospace Engineering, develops Energy storage technology to help California meet its sustainable energy goals. The startup gives new life to used electric batteries vehicles to providing energy storage systems with various applications, such as solar power. The team recently obtained a NSF SBIR Phase I grant and won a Caltech Rocket Fund Grant.

NeoPOSE, founded by Heather siefkes, assistant professor of pediatric intensive care at UC Davis Children’s Hospital, is developing a new technology that could improve the detection of congenital heart defects in newborns. In 2020, Siefkes received internal funding via a proof-of-concept grant from the Venture Catalyst Data, Informatics and Application Launch, or DIAL program. advancing technology towards commercialization.

“Building a new startup to bring technology to market at an early stage is difficult under normal circumstances, but doing so during the constraints of the pandemic illustrates the determination and passion of these entrepreneurs,” said Ryan Sharp, director of Venture Catalyst. “We are delighted to see these startups are advancing new technologies into commercial products that will benefit society and are happy to provide support along the way. “

Other companies that signed agreements to access core UC Davis intellectual property during fiscal year 2020-21 are highlighted below. Two companies have chosen to remain in “stealth mode” for competitive reasons and are not listed.

  • InVixa Co-founded by Amir A. Zeki, Assistant Professor in the Division of Pulmonology, Intensive Care and Sleep Medicine, the company technology is based on a new method using inhaled statins to treat serious respiratory illnesses associated with COVID-19.
  • MILO Machine Intelligent learning optimizer – Co-founded by Hooman Rachidi, professor in the Department of Pathology and Laboratory Medicine, the company has developed a turnkey software tool this provides a fully automated machine learning solution for many different research and business needs.
  • Ohalo Genetics This startup is dedicated to reinventing the art and science of plant breeding through the interplay of molecular selection and quantitative genetics.
  • VasoBio Co-founded by Aijun Wang, professor in the Department of Biomedical Engineering, this biotechnology startup is developing a new coating technology to functionalize vascular grafts that will provide resistance to thrombosis, infection and blood clotting.

Stimulate innovation and entrepreneurship

In order to facilitate the successful translation of research into commercial practice, UC Davis Research Office in 2013 launched Business catalyst, a unit within the Innovation and technology commercialization division. Business catalyst offers several innovative programs that bridge the gap between early stage research and commercialization by enabling and supporting strong academic startups and spin-off companies. In the last fiscal year, Venture Catalyst assisted 24 new startups with 32 team members associated with the university. The startups Venture Catalyst has helped through its range of programs raised approximately $ 223 million in funding in fiscal year 2020-21. 

Milestones for previous startups

Over the past 10 years, a total of 119 startups have emerged from the UC Davis research community with support from Venture Catalyst. About 73% are active today.

  • Shasqi, a clinical stage biotechnology Start this allow patients to beat cancer while decreasing toxicity To summer awarded a Direct Phase 2 Small Business Innovation Research Grant by the National Cancer Institute.
  • Bouncer Technologies, a startup which uses machine learning to detect fraudulent cards, transactions and phones To summer acquired by Stripe, a global technology company that is building an economic infrastructure for the Internet.
  • Develop biosystems, founded by UC Davis Scientists, is dedicated to developing the next generation of products to establish, restore and maintain a healthy newborn gut microbiome. The company recently closed a series of funding that will enable them to improve the health of infants around the world.

[ad_2]